Capability Development Change Request
Summary of Proposed Change
| Original Commitment | Proposed | |
|---|---|---|
| Category 5: R&D Information Management | Committed | Continue (no change) |
| Category 2: Regulatory & Compliance | Committed | Discontinue |
| Category 1: Intellectual Property | Not committed | Add |
Net effect: Still delivering on 2 CapDev categories as required. One category substitution.
Our Commitment to the Contract
We remain fully committed to delivering genuine capability development as part of this grant. The purpose of this Change Request is not to reduce our CapDev obligations, but to ensure the activities we undertake deliver real, lasting capability value given what we now know about the technical landscape.
We acknowledge:
- The contract requires CapDev activities across at least 2 categories
- Minimum spend of approximately $51,000 (5.18% of eligible costs)
- Activities must genuinely build R&D capability, not simply tick boxes
- Any material changes require approval under Clause 8
We are seeking this discussion proactively, before incurring expenditure, to ensure alignment with Callaghan's expectations.
What We Originally Committed To
Original deliverable: "Establish a centralised research information management system to securely store and organise R&D data, ensuring efficient access, compliance, and integration with other internal systems."
Status: In progress. Gitcode reporting refactored. Continuing as planned.
No change requested. This activity remains relevant and we will complete it as committed.
Original deliverable: "Research and secure resources to understand ensure compliance with health and medical data privacy standards."
Current status: Not commenced. Originally due 30 June 2025.
Why we are proposing to discontinue this activity:
At the time of application, we anticipated building and training our own AI models for healthcare conversations. In that context, understanding healthcare data compliance for model training was critical capability development.
The technical landscape has shifted significantly:
- We are now integrating commercial AI APIs (GPT-4, Claude) rather than training proprietary models
- Compliance requirements for API integration are different from model training requirements
- The compliance questions we face are now more about data flow architecture and API terms of service than healthcare data handling for ML training
- Much of this compliance knowledge is being developed through our R&D work itself, rather than requiring separate external capability building
We are not saying compliance doesn't matter—it does, critically. But the capability development activity as originally framed no longer matches our actual capability gap.
Proposed Replacement Activity
Proposed activity: Obtain specialist intellectual property legal advice in relation to the AI and healthcare integration capability being developed.
What this would involve:
As Bridge Point invests in healthcare AI R&D, we are creating potentially protectable intellectual property and valuable confidential know-how. This may include:
- Integration methods and workflow designs
- Data structures and automation logic
- Documentation frameworks and product methodology
- Reusable implementation patterns for healthcare AI
The IP advice would help us understand:
- What IP is being created through our R&D work
- Whether elements should be protected through copyright, confidentiality, trade secrets, or contractual controls
- How to manage ownership of IP created by external consultants
- How to protect reusable methods and frameworks
- What should be documented internally as proprietary knowledge
- What should be disclosed, licensed, or kept confidential
Why this is genuine capability development:
This is not legal advice for a specific transaction. It is capability building—developing Bridge Point's internal understanding of how to identify, protect, and commercialise IP arising from R&D activity. This capability will persist beyond this project and inform how we approach IP in future R&D work.
Estimated cost: $15,000 – $25,000
Budget Impact
| Activity | Original | Proposed |
|---|---|---|
| R&D Information Management (Cat 5) | $36,000 | $36,000 |
| Regulatory & Compliance (Cat 2) | $15,000 | $0 |
| Intellectual Property (Cat 1) | $0 | $15,000 – $25,000 |
| Total CapDev | $51,000 | $51,000 – $61,000 |
Questions for Callaghan
- Is the proposed category substitution (from Category 2 to Category 1) acceptable in principle?
- What documentation or formal process is required to effect this change under Clause 8?
- Are there any concerns with the rationale provided for discontinuing the Regulatory & Compliance activity?
- Is the proposed IP Capability scope and budget ($15K-$25K) appropriate?
Next Steps
- Discuss this proposal with Callaghan contact
- Clarify any concerns or required adjustments
- Submit formal Change Request if approach is agreed in principle
- Procure approved CapDev activities in Q3-Q4 2026
- Submit claims in subsequent reporting periods
Prepared by: Bridge Point
Contract: CONT-96212-N2RD-BRIDG
Date: July 2026